Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1038 | Male Reproduction | ICEECE2012

Mutations and polymorphism of FSH and LH receptors and sperm quality in men with hypergonadotropic hypogonadism without obvious testicular noxa

Di Cairano G. , Cantara S. , Collodel G. , Moretti E. , Taglianetti S. , Mazzi L. , Pacini F.

Introduction: Inactivating mutations in LH or FSH receptors (R) are known causes of gonadotrophins resistance.Aim: This study aims at evaluating the presence of mutations and polymorphisms of FSHR and LHR and sperm quality in men with hypergonadotropic hypogonadism without obvious testicular noxa.Patients and methods: We selected 8 males with elevated levels of FSH and/or LH and normal levels of testosterone. Sperm parameters were ...

ea0029p1750 | Thyroid cancer | ICEECE2012

Indoleamine 2,3-dioxygenase 1 (IDO1) and thyroid carcinoma: Ret/PTC appears as a strong genetic determinant for IDO1 expression

Menicali E. , Moretti S. , Voce P. , Melillo R. , Sponziello M. , Filetti S. , Avenia N. , Santoro M. , Puxeddu E.

Indoleamine 2,3-dioxygenase 1 (IDO1) is a single chain oxidoreductase that catalyzes tryptophan degradation to kynurenine. In cancer, it appears to exert an immunosuppressive function as part of an acquired mechanism of immune escape. In view of this notion, IDO1 has started to be considered a novel target in cancer therapy. Objective of this study was to evaluate IDO1 expression in papillary thyroid carcinoma (PTC) and to correlate its expression with genetic determinants of ...